How Miniaturized Liquid Flow Sensors Are Revolutionizing Subcutaneous Drug Delivery

The COVID-19 pandemic has strengthened the push toward digitalization as well as patient-centric solutions in healthcare. The increasing demand for self-treatment, as well as the rise of biotechnology and precision medicine, give new meaning to smart drug tracking. By implementing miniaturized liquid flow sensors in wearable devices, subcutaneous drug delivery will reach the next level. This will result in a benefit for patients, doctors, nursing staff, pharmaceutical companies, and the healthcare system.